Barkat Pharmed Co. is one of the largest pharmaceutical holding Companies with more than 20 subsidiaries. The company's name was was changed to “Tadbir innovation pharmaceutical company” in 2010. As a knowledge-based economic complex , the company has focused on health care products.
The core activity of the company is to move towards fulfilling the 20-Year National Vision of the Islamic Republic of Iran for the dawn of the Solar Calendar Year 1404 to move in line with the comprehensive scientific map of Iran in terms of social responsibility and respecting human values.
The contribution to the development of social justice, and to increase the access of the deprived people to new health care products through the production of drugs with affordable prices are among the company’s goals.
The company macro-level orientation is to enter into the field of modern medicine such as biotechnology, new drug delivery technologies based on nanotechnology, sustained release medicines and the development of cellular and molecular biology industries including cell therapy, gene therapy, immunotherapy and tissue engineering.
The subsidiaries of Barkat Pharmaceuticals holding company are operating in the fields of developing and transferring technical knowledge , commercialization of new technologies and drug manufacturing (ranging from active pharmaceutical ingredients to finished products, business services, export, import and distribution
Our company has acquired 14 percent of the country total pharmaceutical market and could produce more than 420 different products through its subsidiaries.
The major shares of the subsidiaries including Alborz Investment Company and most of its subsidiaries such as Sobhan Darou Pharmaceuticals Co., Iran Daru Co., Tolid Daru Co., Alborz Darou Co. and etc, have been listed and offered in The Tehran Stock Exchange and are public companies.